News

Hot off the Press

Discover news about Xcellerant Ventures, portfolio companies and the industry landcape.

Xcellerant Ventures News

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Portfolio Company News

Nanodropper Forbes Profile

Nanodropper Forbes Profile

Content origionally posted on Forbes: https://www.forbes.com/profile/nanodropper/?sh=68bd9c044196 About Nanodropper Song, Baker, Andrews and Steger cofounded Nanodropper, a patented twist-on adapter that produces eye drops with 70% less volume than a normal eye drop,...

Eyes on the Patient

Eyes on the Patient

Content origionally posted on Mayo Clinic's blog: https://newsnetwork.mayoclinic.org/discussion/alumni-eyes-on-the-patient/ Editor's Note: This article is the first in the Young Innovators series, originally published in Mayo Clinic's Alumni Magazine. Each article...

Why Xcellerant Ventures

We firmly believe that founders deserve more than just a check. In fact, investors should empower founds to help promote a vibrant ecosystem that allows groundbreaking ideas to enhance accessibility, efficiency, affordability, and quality of healthcare.

Futhermore, our GPs’ experience is unique and perfectly aligned with the needs of the market. They bring a combined experience of over seven decades in medical technologies, law, and entrepreneurship.

Through their personal experience, domain expertise, and unique network, they provide hands-on advice, education, and invaluable guidance to xcellerate startups and drive their success.

Founder Focus

We believe that the quality of the founders makes a huge difference in creating and fostering a successful partnership. We pick founders that are humble, willing to take advice, lead from the front, and are driven to change the world.

Moreover, we actively seek out founders and companies that have been overlooked by other venture capitalists, providing opportunities, expertise, and funding to individuals who have been traditionally underrepresented in the innovation economy.